Individual healthcare-seeking pathways for tuberculosis in Nigeria’s private sector during the COVID-19 pandemic

Abstract

[1]  M. Pai,et al.  Tuberculosis service disruptions and adaptations during the first year of the COVID-19 pandemic in the private health sector of two urban settings in Nigeria—A mixed methods study , 2023, PLOS global public health.

[2]  Abdu A. Adamu,et al.  Tuberculosis care quality in urban Nigeria: A cross-sectional study of adherence to screening and treatment initiation guidelines in multi-cadre networks of private health service providers , 2022, PLOS global public health.

[3]  T. Kirby.  Global tuberculosis progress reversed by COVID-19 pandemic , 2021, The Lancet Respiratory Medicine.

[4]  M. Pai,et al.  Tuberculosis in times of COVID-19 , 2021, Journal of Epidemiology & Community Health.

[5]  T. Cohen,et al.  The impact of COVID-19 on TB: a review of the data , 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  R. Duarte,et al.  Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects , 2021, Pulmonology.

[7]  O. Chukwuogo,et al.  Impact of COVID-19 on TB active case finding in Nigeria. , 2020, Public health action.

[8]  B. Alisjahbana,et al.  Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia , 2020, The Lancet regional health. Western Pacific.

[9]  Charity Oga-Omenka,et al.  TB and COVID – Public and private health sectors adapt to a new reality , 2020, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.

[10]  J. Boffa,et al.  Commentary: Lessons from the COVID-19 global health response to inform TB case finding , 2020, Healthcare.

[11]  J. Boffa,et al.  Understanding the gaps in DR-TB care cascade in Nigeria: A sequential mixed-method study , 2020, Journal of clinical tuberculosis and other mycobacterial diseases.

[12]  G. Ippolito,et al.  Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020 , 2020, Emerging infectious diseases.

[13]  O. Adewole.  Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria. , 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  C. Lange,et al.  COVID-19 -Tuberculosis interactions: When dark forces collide , 2020, Indian Journal of Tuberculosis.

[15]  D. Menzies,et al.  Ease and equity of access to free DR-TB services in Nigeria- a qualitative analysis of policies, structures and processes , 2020, International Journal for Equity in Health.

[16]  D. Menzies,et al.  Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review , 2020, BMJ Global Health.

[17]  N. Berhe,et al.  Delay in treatment initiation and its association with clinical severity and infectiousness among new adult pulmonary tuberculosis patients in Tigray, northern Ethiopia , 2020, BMC Infectious Diseases.

[18]  M. Pai,et al.  Quality of tuberculosis care in the private health sector☆ , 2020, Journal of clinical tuberculosis and other mycobacterial diseases.

[19]  S. Dixon,et al.  Patient pathways of tuberculosis care-seeking and treatment: an individual-level analysis of National Health Insurance data in Taiwan , 2020, BMJ Global Health.

[20]  L. Hsu,et al.  Determinants of delayed diagnosis and treatment of tuberculosis in Cambodia: a mixed-methods study , 2020, Infectious Diseases of Poverty.

[21]  L. Cuevas,et al.  Tackling two pandemics: a plea on World Tuberculosis Day , 2020, The Lancet Respiratory Medicine.

[22]  E. Corbett,et al.  Missed opportunities for diagnosis and treatment in patients with tuberculosis symptoms: a systematic review , 2020 .

[23]  R. Subbaraman,et al.  Closing gaps in the tuberculosis care cascade: an action-oriented research agenda , 2020, Journal of clinical tuberculosis and other mycobacterial diseases.

[24]  I. Aliyu,et al.  Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria , 2019, PloS one.

[25]  S. Bello,et al.  Empirical evidence of delays in diagnosis and treatment of pulmonary tuberculosis: systematic review and meta-regression analysis , 2019, BMC Public Health.

[26]  D. Menzies,et al.  Rates and timeliness of treatment initiation among drug-resistant tuberculosis patients in Nigeria- A retrospective cohort study , 2019, PloS one.

[27]  R. Atun,et al.  Health systems performance in managing tuberculosis: analysis of tuberculosis care cascades among high-burden and non-high-burden countries , 2019, Journal of global health.

[28]  J. Kishore,et al.  Tuberculosis patients not covered by treatment in public health services: findings from India's National Family Health Survey 2015–16 , 2018, Tropical medicine & international health : TM & IH.

[29]  A. Worku,et al.  Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: systematic review and meta-analysis , 2017, BMC Pulmonary Medicine.

[30]  R. Valliant,et al.  Survey Weights: A Step-by-step Guide to Calculation , 2017 .

[31]  D. Chin,et al.  Finding the Missing Patients With Tuberculosis: Lessons Learned From Patient-Pathway Analyses in 5 Countries , 2017, The Journal of infectious diseases.

[32]  N. Mistry,et al.  Pulmonary tuberculosis in Patna, India: Durations, delays, and health care seeking behaviour among patients identified through household surveys , 2017, Journal of epidemiology and global health.

[33]  P. Lefèvre,et al.  Patients pathways to tuberculosis diagnosis and treatment in a fragmented health system: a qualitative study from a south Indian district , 2017, BMC Public Health.

[34]  Yu He,et al.  Total delay in treatment among tuberculous meningitis patients in China: a retrospective cohort study , 2017, BMC Infectious Diseases.

[35]  H. Alsdurf,et al.  Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[36]  N. Konduri,et al.  Engagement of the private pharmaceutical sector for TB control: rhetoric or reality? , 2017, Journal of pharmaceutical policy and practice.

[37]  R. Ananthakrishnan,et al.  How do patients access the private sector in Chennai, India? An evaluation of delays in tuberculosis diagnosis. , 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[38]  E. Bismark,et al.  Determinants of Treatment Delays among Pulmonary Tuberculosis Patients in Enugu Metropolis, South-East, Nigeria , 2015 .

[39]  M. Pai,et al.  Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional study. , 2015, The Lancet. Infectious diseases.

[40]  Jenny Liu,et al.  Care-seeking at patent and proprietary medicine vendors in Nigeria , 2015, BMC Health Services Research.

[41]  S. Egwaga,et al.  Health care-seeking behaviour among people with cough in Tanzania: findings from a tuberculosis prevalence survey. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[42]  K. Ukwaja,et al.  Transaction costs of access to health care: Implications of the care-seeking pathways of tuberculosis patients for health system governance in Nigeria , 2015, Global public health.

[43]  D. Silva,et al.  Health care seeking behavior and patient delay in tuberculosis diagnosis. , 2015, Cadernos de saude publica.

[44]  Jenny X. Liu,et al.  A Systematic Review of the Role of Proprietary and Patent Medicine Vendors in Healthcare Provision in Nigeria , 2015, PloS one.

[45]  D. Oshi,et al.  Evaluation of Patient Satisfaction with Tuberculosis Services in Southern Nigeria , 2015, Health services insights.

[46]  P. Aaby,et al.  Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study , 2014, BMJ Open.

[47]  C. Sreeramareddy,et al.  Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[48]  Q. Gao,et al.  Factors associated with delayed tuberculosis diagnosis in China. , 2013, European journal of public health.

[49]  K. Ukwaja,et al.  Healthcare-seeking behavior, treatment delays and its determinants among pulmonary tuberculosis patients in rural Nigeria: a cross-sectional study , 2013, BMC Health Services Research.

[50]  P. Tattevin,et al.  Factors associated with patient and health care system delay in the diagnosis of tuberculosis in France. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[51]  P. Sonnenberg,et al.  Missed opportunities in TB diagnosis: a TB Process-Based Performance Review tool to evaluate and improve clinical care , 2011, BMC public health.

[52]  F. Cobelens,et al.  Long Delays and Missed Opportunities in Diagnosing Smear-Positive Pulmonary Tuberculosis in Kampala, Uganda: A Cross-Sectional Study , 2010, PloS one.

[53]  J. Porter,et al.  What 'outliers' tell us about missed opportunities for tuberculosis control: a cross-sectional study of patients in Mumbai, India , 2010, BMC public health.

[54]  C. Sreeramareddy,et al.  Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature , 2009, BMC infectious diseases.

[55]  Purwanta,et al.  Journeys to tuberculosis treatment: a qualitative study of patients, families and communities in Jogjakarta, Indonesia , 2009, BMC public health.

[56]  V. Chongsuvivatwong,et al.  Dose-response relationship between treatment delay of smear-positive tuberculosis patients and intra-household transmission: a cross-sectional study. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[57]  G. Maartens,et al.  Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: A cross-sectional study , 2008, BMC infectious diseases.

[58]  J. Hargrove,et al.  The Effect of Diagnostic Delays on the Drop-Out Rate and the Total Delay to Diagnosis of Tuberculosis , 2008, PloS one.

[59]  B. Terluin,et al.  Cost-effectiveness of a workplace intervention for sick-listed employees with common mental disorders: design of a randomized controlled trial , 2008, BMC public health.

[60]  A. Thorson,et al.  Health care seeking among individuals with cough and tuberculosis: a population-based study from rural India. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[61]  Y. Chechulin,et al.  Health care seeking behaviour for tuberculosis symptoms in Kiev City, Ukraine. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[62]  Shawn A. Ross,et al.  Survey Methodology , 2005, The SAGE Encyclopedia of the Sociology of Religion.

[63]  M. Uplekar,et al.  Public-private mix for DOTS implementation: what makes it work? , 2004, Bulletin of the World Health Organization.

[64]  O. Odusanya,et al.  Patterns of delays amongst pulmonary tuberculosis patients in Lagos, Nigeria , 2004, BMC Public Health.

[65]  D. Needham,et al.  Socio‐economic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia , 2001, Tropical medicine & international health : TM & IH.

[66]  E. Johansson,et al.  Gender and tuberculosis control: perspectives on health seeking behaviour among men and women in Vietnam. , 2000, Health policy.

[67]  S. Asuke,et al.  Strategic Engagement of Private Facilities to Increase Public-Private Mix (PPM) Contribution to Nigeria Tuberculosis Case Notification , 2022, Journal of Tuberculosis Research.

[68]  N. Arinaminpathy,et al.  Supplement to: Constructing care cascades for active tuberculosis: a strategy for program monitoring and identifying gaps in quality of care Corresponding author: , 2019 .

[69]  M. Raviglione,et al.  Journal of Clinical Tuberculosis and Other Mycobacterial Diseases , 2017 .

[70]  I. Hazarika.  Role of Private Sector in Providing Tuberculosis Care: Evidence from a Population-based Survey in India , 2011, Journal of global infectious diseases.

[71]  D. Needham,et al.  Patient care seeking barriers and tuberculosis programme reform: a qualitative study. , 2004, Health policy.

[72]  A. Muynck,et al.  Health care seeking behavior of pulmonary tuberculosis patients visiting TB Center Rawalpindi. , 2001, JPMA. The Journal of the Pakistan Medical Association.